mercoledì 18 Novembre 2020 ore 16:45 - 19:00
“Designing the future European Health Union? Scaling-up Ambitions, Powering Resilience” – this is the title of the Health Symposium organised (18 November, 16:45 – 19:00) by the Institute for Competitiveness (I-Com).
The event provided an open and transparent forum to debate on two key priorities on the EU health agenda, which the Commission is about to outline by the end of the year, the Cancer Plan and the pharmaceutical strategy. The Symposium was also an opportunity to take stock of the proposal for a strengthened European Health Union, announced by Ursula von der Leyen in her first SOTEU address and detailed in the package of initiatives presented last week by the Commission as a long-term response to the critical issues emerging during the Covid-19 crisis.
The Symposium gave the floor to 15 high-level speakers, including representatives from EU and national institutions, companies, research, business and patient organisations, and brought more than 100 stakeholders from Brussels and the Member States.
Among the speakers, there were: Walter Ricciardi, Chair of the Horizon Europe Mission Board for Cancer, MEP Tomislav Sokol, Member the Special Committee on Beating Cancer. Other speakers include: DG SANTE’s Sylvain Giraud, EMA’s Tony Humphreys, WHO’s Sarah Garner, Johnson & Johnson’s Anouk De Vroey, ECPC’s Antonella Cardone, EFPIA’s Elizabeth Kuiper, ESMO’s Rosa Giuliani. MEPs Dolors Montserrat, Co-Chair of the ENVI Committee’s Health Working Group and Patrizia Toia, Vice-Chair ITRE Committee, sent a written contribution to the discussion.
I-Com presented a paper to contribute to shaping the discussion and was represented by Stefano da Empoli, President, Eleonora Mazzoni, Head of Innovation Area, and Mattia Ceracchi, Head of EU Affairs.
This symposium represented a milestone of I-Com 2020 Brussels initiative “PEOPLE, PLANET, PROGRESS”, which aims at monitoring the political priorities of the new European Commission and influencing the EU public debate in line with the recommendations outlined in the I-Com Blueprint “Innovative Europe: The Way Forward. Taking Stock and Thinking Ahead” (February 2020).
[tp no_translate]Antonella CARDONE
Director of European Cancer Patient Coalition (ECPC)[/tp]
[tp no_translate]Stefano DA EMPOLI
President I-Com – the Institute for Competitiveness[/tp]
[tp no_translate] Anouk DE VROEY
Senior Director, Government Affairs & Policy EMEA, Johnson & Johnson[/tp]
[tp no_translate] Sarah GARNER
Acting Programme Manager for Access to Medicines and Health Products, WHO Regional Office for Europe[/tp]
[tp no_translate]Sylvain GIRAUD
Head of Unit, Medical products: quality, safety and innovation, DG SANTE, European Commission[/tp]
[tp no_translate]Rosa GIULIANI
Director of Public Policy, European Society for Medical Oncology – ESMO[/tp]
[tp no_translate]Tony HUMPHREYS
Head of the Regulatory Science and Innovation Task Force, European Medicines Agency (EMA)[/tp]
[tp no_translate]Elizabeth KUIPER
Executive Director Public Affairs EFPIA, the European Federation of Pharmaceutical Industries and Associations[/tp]
[tp no_translate]Yann LE CAM
Chief Executive Officer, Eurordis – European Organisation for Rare Diseases[/tp]
[tp no_translate]Eleonora MAZZONI
Head of Innovation Area, I-Com[/tp]
[tp no_translate]Dolors MONTSERRAT
MEP, Co-Chair of the Health Working Group, ENVI Committee [/tp]
[tp no_translate]Walter RICCIARDI
Chair of the Horizon Europe Mission Board for Cancer[/tp]
[tp no_translate]Tomislav SOKOL
MEP, Member of the Special Committee on Beating Cancer, EPP Group [/tp]
[tp no_translate]Patrizia TOIA
MEP, Vice-Chair ITRE Committee[/tp]
To confirm your participation please email us at email@example.com by Tuesday 17th November.